Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia

Urology

Volumn 67, Issue 4, 2006, Pages 731-736

  Rackley, Raymond ^a   Weiss, Jeffrey P ^b   Rovner, Eric S ^c   Wang, Joseph T ^d   Guan, Zhonghong ^d  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TOLTERODINE;

ADULT; ARTICLE; BLURRED VISION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; MULTICENTER STUDY; NIGHT; NOCTURIA; OVERACTIVE BLADDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SOMNOLENCE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME; URGE INCONTINENCE; URINE RETENTION; XEROSTOMIA;

BENZHYDRYL COMPOUNDS; CRESOLS; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; URINARY INCONTINENCE; URINATION DISORDERS;

EID: 33646477041     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.10.061     Document Type: Article

References (15)

1. Abrams P., Cardozo L., Fall M., et al. The standardisation of terminology in lower urinary tract function. report from the Standardisation Sub-Committee of the International Continence Society. Urology 61 (2003) 37-49
2. van Kerrebroeck P., Abrams P., Chaikin D., et al. The standardisation of terminology in nocturia. report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn 21 (2002) 179-183
3. Jennum P. Sleep and nocturia. BJU Int 90 suppl 3 (2002) 21-24
4. Coyne K.S., Zhou Z., Bhattacharyya S.K., et al. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int 92 (2003) 948-954
5. Kobelt G., Borgstrom F., and Mattiasson A. Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia. BJU Int 91 (2003) 190-195
6. Asplund R., and Aberg H.E. Nocturia and health in women aged 40-64 years. Maturitas 35 (2000) 143-148
7. van Dijk L., Kooij D.G., and Schellevis F.G. Nocturia in the Dutch adult population. BJU Int 90 (2002) 644-648
8. Wein A., Lose G.R., and Fonda D. Nocturia in men, women and the elderly. a practical approach. BJU Int 90 suppl 3 (2002) 28-31
9. Abrams P., Mattiasson A., Lose G.R., et al. The role of desmopressin in the treatment of adult nocturia. BJU Int 90 suppl 3 (2002) 32-36
10. Marinkovic S.P., Gillen L.M., and Stanton S.L. Managing nocturia. BMJ 328 (2004) 1063-1066
11. Olsson B., and Szamosi J. Multiple dose pharmacokinetics of a new once daily extended release tolterodine formulation versus immediate release tolterodine. Clin Pharmacokinet 40 (2001) 227-235
12. European Agency for the Evaluation of Medicinal Products and Committee for Proprietary Medicinal Products. Note for Guidance on the Clinical Investigation of Medicinal Products for the Treatment of Urinary Incontinence (2002). http://www.emea.eu-int/pdfs/human/ewp/001801.en.pdf London, Available at http://www.emea.eu-int/pdfs/human/ewp/001801.en.pdf
13. Coyne K.S., Matza L., Thompson C., et al. A comparison of three approaches to analyze urinary urgency as a treatment outcome (2005) Presented at the 35th Annual Meeting of the International Continence Society, Montreal, Quebec, Canada, August 28 to September 2
14. Coyne K, Matza L, Thompson C, et al: From an OAB patient perspective: quality of life improves when frequency and urgency improve. Available at: http://www.continet.org/publications/2005/PDF/0437.pdf. Accessed July 29, 2005
15. van Kerrebroeck P., Kreder K., Jonas U., et al. Tolterodine once-daily. superior efficacy and tolerability in the treatment of the overactive bladder. Urology 57 (2001) 414-421